?-thalassemia major is characterised by grossly defective synthesis of haemoglobin A along with increased production of haemoglobin F, impaired red blood cells production and increased haemolysis of the defective red blood cells. Affected individuals are dependent on repeated blood transfusions and iron chelating therapy. Patients on blood transfusion may develop complications related to iron overload and adverse effects of chelating agent which has harmful effects on many organs in the body including the kidneys. The present study was aimed to investigate renal functions in paediatric patients with transfusion dependent ?-thalassemia major using deferasirox. This study consisted of two groups of ?-thalassemia patient
Introduction: Deferasirox is a new oral iron chelating agent which has been administered in β-thala...
Thalassemia is a hereditary disorder characterised by changes in organ function and iron overload re...
The management of beta thalassemia may require periodic blood transfusions, iron chelation therapy, ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
BACKGROUND: Thalassemia is a disorder of inherited blood and inticated by the abnormal hemoglobin. T...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Some patients with \u3b2 thalassaemia experience non-progressive creatinine increases with deferasir...
Background. The life of patients with β-thalassemia major depends on blood transfusion. Regular bloo...
Background: Inblood transfusion related thalassemia patients, high iron state is observed because of...
PubMedID: 11095025In patients with ß-thalassemia major, the most important cause of mortality and mo...
Introduction: Deferasirox is a new oral iron chelating agent which has been administered in β-thala...
Thalassemia is a hereditary disorder characterised by changes in organ function and iron overload re...
The management of beta thalassemia may require periodic blood transfusions, iron chelation therapy, ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
BACKGROUND: Thalassemia is a disorder of inherited blood and inticated by the abnormal hemoglobin. T...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Introduction: Renal dysfunction is a frequent complication in patients suffering from β-thalassemia ...
Some patients with \u3b2 thalassaemia experience non-progressive creatinine increases with deferasir...
Background. The life of patients with β-thalassemia major depends on blood transfusion. Regular bloo...
Background: Inblood transfusion related thalassemia patients, high iron state is observed because of...
PubMedID: 11095025In patients with ß-thalassemia major, the most important cause of mortality and mo...
Introduction: Deferasirox is a new oral iron chelating agent which has been administered in β-thala...
Thalassemia is a hereditary disorder characterised by changes in organ function and iron overload re...
The management of beta thalassemia may require periodic blood transfusions, iron chelation therapy, ...